Annual Accounts Receivable
$535.60 M
+$52.40 M+10.84%
31 December 2023
Summary:
CME annual accounts receivable is currently $535.60 million, with the most recent change of +$52.40 million (+10.84%) on 31 December 2023. During the last 3 years, it has risen by +$101.10 million (+23.27%). CME annual accounts receivable is now -3.20% below its all-time high of $553.30 million, reached on 31 December 2018.CME Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$629.40 M
+$29.90 M+4.99%
30 September 2024
Summary:
CME quarterly accounts receivable is currently $629.40 million, with the most recent change of +$29.90 million (+4.99%) on 30 September 2024. Over the past year, it has increased by +$93.80 million (+17.51%). CME quarterly accounts receivable is now -21.30% below its all-time high of $799.70 million, reached on 31 March 2020.CME Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CME Accounts Receivable Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | +17.5% |
3 y3 years | +23.3% | +44.9% |
5 y5 years | +8.9% | +28.0% |
CME Accounts Receivable High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +23.3% | -13.0% | +44.9% |
5 y | 5 years | at high | +23.3% | -21.3% | +44.9% |
alltime | all time | -3.2% | +1777.6% | -21.3% | +1435.7% |
CME Accounts Receivable History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $629.40 M(+5.0%) |
June 2024 | - | $599.50 M(-4.6%) |
Mar 2024 | - | $628.20 M(+17.3%) |
Dec 2023 | $535.60 M(+10.8%) | $535.60 M(-4.1%) |
Sept 2023 | - | $558.40 M(-6.8%) |
June 2023 | - | $599.40 M(-17.2%) |
Mar 2023 | - | $723.60 M(+49.8%) |
Dec 2022 | $483.20 M(+11.2%) | $483.20 M(-16.7%) |
Sept 2022 | - | $580.20 M(-0.4%) |
June 2022 | - | $582.30 M(-4.4%) |
Mar 2022 | - | $608.90 M(+40.1%) |
Dec 2021 | $434.50 M(-5.8%) | $434.50 M(-7.6%) |
Sept 2021 | - | $470.40 M(-7.7%) |
June 2021 | - | $509.60 M(-6.8%) |
Mar 2021 | - | $547.00 M(+18.6%) |
Dec 2020 | $461.30 M(-6.2%) | $461.30 M(-6.0%) |
Sept 2020 | - | $490.90 M(-7.7%) |
June 2020 | - | $532.10 M(-33.5%) |
Mar 2020 | - | $799.70 M(+62.6%) |
Dec 2019 | $491.80 M(-11.1%) | $491.80 M(-9.9%) |
Sept 2019 | - | $545.70 M(-8.1%) |
June 2019 | - | $593.70 M(+6.1%) |
Mar 2019 | - | $559.50 M(+1.1%) |
Dec 2018 | $553.30 M(+53.8%) | $553.30 M(+43.2%) |
Sept 2018 | - | $386.30 M(-11.0%) |
June 2018 | - | $433.90 M(-2.3%) |
Mar 2018 | - | $444.10 M(+23.5%) |
Dec 2017 | $359.70 M(-1.3%) | $359.70 M(-7.8%) |
Sept 2017 | - | $390.30 M(-6.3%) |
June 2017 | - | $416.40 M(-2.4%) |
Mar 2017 | - | $426.60 M(+17.1%) |
Dec 2016 | $364.40 M(+1.8%) | $364.40 M(-7.9%) |
Sept 2016 | - | $395.70 M(-7.3%) |
June 2016 | - | $427.00 M(+9.7%) |
Mar 2016 | - | $389.30 M(+8.8%) |
Dec 2015 | $357.80 M(+4.9%) | $357.80 M(-1.6%) |
Sept 2015 | - | $363.80 M(-9.0%) |
June 2015 | - | $399.90 M(+4.3%) |
Mar 2015 | - | $383.40 M(+12.4%) |
Dec 2014 | $341.20 M(+12.7%) | $341.20 M(-1.0%) |
Sept 2014 | - | $344.80 M(+3.0%) |
June 2014 | - | $334.90 M(-2.8%) |
Mar 2014 | - | $344.60 M(+13.8%) |
Dec 2013 | $302.70 M | $302.70 M(-2.9%) |
Sept 2013 | - | $311.90 M(-13.1%) |
June 2013 | - | $359.10 M(+16.1%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2013 | - | $309.20 M(+15.6%) |
Dec 2012 | $267.50 M(-7.6%) | $267.50 M(-9.9%) |
Sept 2012 | - | $296.90 M(-11.9%) |
June 2012 | - | $336.90 M(-6.4%) |
Mar 2012 | - | $360.00 M(+24.4%) |
Dec 2011 | $289.40 M(-2.7%) | $289.40 M(-21.7%) |
Sept 2011 | - | $369.50 M(-4.2%) |
June 2011 | - | $385.80 M(-2.1%) |
Mar 2011 | - | $394.00 M(+32.4%) |
Dec 2010 | $297.50 M(+19.8%) | $297.50 M(-10.8%) |
Sept 2010 | - | $333.40 M(+0.8%) |
June 2010 | - | $330.80 M(+4.4%) |
Mar 2010 | - | $316.90 M(+27.6%) |
Dec 2009 | $248.30 M(+6.1%) | $248.30 M(-5.9%) |
Sept 2009 | - | $264.00 M(-6.5%) |
June 2009 | - | $282.40 M(+1.0%) |
Mar 2009 | - | $279.50 M(+19.4%) |
Dec 2008 | $234.00 M(+24.8%) | $234.00 M(-31.2%) |
Sept 2008 | - | $339.94 M(+43.2%) |
June 2008 | - | $237.35 M(-5.8%) |
Mar 2008 | - | $251.98 M(+34.4%) |
Dec 2007 | $187.49 M(+54.8%) | $187.49 M(-5.7%) |
Sept 2007 | - | $198.85 M(+25.6%) |
June 2007 | - | $158.30 M(-2.3%) |
Mar 2007 | - | $162.08 M(+33.8%) |
Dec 2006 | $121.13 M(+39.3%) | $121.13 M(-3.9%) |
Sept 2006 | - | $126.00 M(-2.1%) |
June 2006 | - | $128.69 M(+11.0%) |
Mar 2006 | - | $115.98 M(+33.3%) |
Dec 2005 | $86.98 M(+10.3%) | $86.98 M(-18.9%) |
Sept 2005 | - | $107.19 M(+10.6%) |
June 2005 | - | $96.88 M(-2.1%) |
Mar 2005 | - | $98.97 M(+25.6%) |
Dec 2004 | $78.83 M(+48.8%) | $78.83 M(-6.0%) |
Sept 2004 | - | $83.88 M(+2.7%) |
June 2004 | - | $81.65 M(+4.2%) |
Mar 2004 | - | $78.34 M(+47.9%) |
Dec 2003 | $52.97 M(+4.1%) | $52.97 M(-9.0%) |
Sept 2003 | - | $58.20 M(-16.0%) |
June 2003 | - | $69.32 M(+8.8%) |
Mar 2003 | - | $63.71 M(+25.2%) |
Dec 2002 | $50.87 M(+24.1%) | $50.87 M(+8.9%) |
Sept 2002 | - | $46.69 M(-3.9%) |
June 2002 | - | $48.60 M(+12.0%) |
Mar 2002 | - | $43.40 M(+5.9%) |
Dec 2001 | $40.99 M(+43.7%) | $40.99 M |
Dec 2000 | $28.53 M | - |
FAQ
- What is CME annual accounts receivable?
- What is the all time high annual accounts receivable for CME?
- What is CME quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for CME?
- What is CME quarterly accounts receivable year-on-year change?
What is CME annual accounts receivable?
The current annual accounts receivable of CME is $535.60 M
What is the all time high annual accounts receivable for CME?
CME all-time high annual accounts receivable is $553.30 M
What is CME quarterly accounts receivable?
The current quarterly accounts receivable of CME is $629.40 M
What is the all time high quarterly accounts receivable for CME?
CME all-time high quarterly accounts receivable is $799.70 M
What is CME quarterly accounts receivable year-on-year change?
Over the past year, CME quarterly accounts receivable has changed by +$93.80 M (+17.51%)